Ozempic-like drugs used to treat type 2 diabetes and obesity may also treat migraine, even when the medications don't trigger weight loss, early research suggests. A preliminary report, published ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial ...

A small trial found that taking the GPL-1 medication liraglutide reduced headache frequency in people with obesity.

Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study showing the GLP-1 receptor agonist provided significant relief to sufferers ...

Headaches are a common and frustrating side effect some people experience while taking the popular weight loss drug Ozempic, but the medication itself may not be to blame. According to fitness and ...

While both Wegovy and Ozempic list “headache” as a common side effect that was found during the drugs’ clinical trials, many patients are saying that what they’re experiencing is not your ...